Ministry of Health Clinical Laboratory Directory is designed to standardize the work of the testing laboratories of nationwide medical institutions. It is the first time in recent years to approve the addition of new detection technology, i.e., EB virus Rta protein antibody IgG detection, which marks that all medical institutions in the country can carryout the clinical examination project, as well as lays a solid foundation forthe next sales work.
Meanwhile,many newspapers and magazines such as Health News and Clinical Laboratory Medicine have also recently published some articles from some scholars so as to pay close attention to the early diagnosis of nasopharyngeal carcinoma and especially to recognize the reagent for early diagnosis of Rta nasopharyngeal carcinoma developed independently by Tarcine BioMed Inc.,indicating that the reagent can be used as a new-generation tumor marker for the early screening and auxiliary diagnosis of nasopharyngeal carcinoma, as well as providing a basis for Rta promotion in the national market!